Fluralaner Spot-on Solution (for Pets)
Core active ingredient: Fluralaner (an isoxazoline insecticide and acaricide). It contains no unnecessary additives and features high purity. After topical administration, it rapidly penetrates the skin, hair and subcutaneous tissue, and is slowly absorbed into the bloodstream to exert a long-acting anthelmintic effect. It undergoes minimal metabolism and is mainly excreted in feces in its original form, imposing little burden on the pet's body with high safety.
|
Comparison Dimension |
This Product (Fluralaner Spot-on Solution) |
Conventional Competitors (e.g., imidacloprid, fipronil spot-on solutions) |
|
Duration of action |
Up to 12 weeks (8 weeks for cats with Dermacentor variabilis infestation), extremely low administration frequency |
Most require administration every 4 weeks; frequent dosing is prone to omission by pet owners |
|
Anthelmintic scope |
Covers fleas + various common ticks, and can assist in the treatment of flea allergic dermatitis |
Some target only fleas or have a limited coverage of tick species, with no adjuvant therapeutic effect on dermatitis |
|
Resistance |
No cross-resistance with amidines, macrolides, etc.; stable efficacy with long-term use |
Long-term use of some products easily leads to cross-resistance, resulting in reduced anthelmintic efficacy |
|
Applicable scenarios |
Suitable for both dogs and cats; can be used for breeding dogs, pregnant/lactating bitches; adaptive to various body sizes |
Some are for dogs or cats only; cautious use for pregnant/lactating pets; limited adaptability to different body sizes |
|
Safety |
Low metabolic burden, few and mild adverse reactions that resolve spontaneously |
Some products are prone to adverse reactions such as skin irritation and vomiting, imposing certain metabolic pressure on pets' bodies |
Case 1: Mixed flea and tick infestation in a dog
Pet information: 2-year-old Golden Retriever, 25kg, frequent outdoor activities. On presentation, adult fleas, flea eggs were found on the body, ticks attached to the postauricular and back areas, accompanied by pruritus and mild erythema (suspected flea allergic dermatitis).
Usage regimen: Canine formulation 3.57mL (1.0g fluralaner) at a dosage of ≥25mg per kg body weight, applied topically to the skin of the shoulder blade area on the back, administered every 12 weeks.
Efficacy: All fleas on the body died within 24 hours after administration, and ticks fell off gradually; pruritus and erythema relieved 3 days later; skin returned to normal with no new flea or tick infestation 1 week later; no recurrence of fleas or ticks during 3 months of continuous use. The pet was in good spirits with no adverse reactions.
Case 2: Dermacentor variabilis infestation in a cat
Pet information: 1-year-old British Shorthair, 3.5kg, often goes outdoors and contacts grassland. Dermacentor variabilis were found attached to the body, frequent scratching at the bite sites with mild skin damage.
Usage regimen: Feline formulation 0.4mL (112.5mg fluralaner) at a dosage of ≥40mg per kg body weight, applied topically to the skin at the base of the skull, administered every 8 weeks.
Efficacy: All ticks fell off within 48 hours after administration, and pruritus at bite sites reduced; skin damage healed with no secondary infection 1 week later; no recurrent tick infestation with periodic administration thereafter. The pet’s scratching behavior disappeared with stable skin condition.
Case 3: Long-term preventive use
Pet information: 1-year-old Toy Poodle, 8kg, indoor feeding with regular outdoor walking, no obvious parasitic infestation. The owner intended for long-term prevention of fleas and ticks.
Usage regimen: Canine formulation 1.79mL (0.5g fluralaner), administered every 12 weeks and applied to the skin of the hip area on the back.
Efficacy: No fleas or ticks were found on the pet’s body during 6 months of continuous use, with no skin irritation, allergy or other adverse reactions. The pet had smooth fur and good spirits, effectively avoiding the risk of parasitic infestation during outdoor activities.
Case 4: Lyme disease prevention and control in a dog (tick-borne transmission block)
Pet information: 3-year-old Labrador Retriever, 30kg, raised in a Lyme disease-endemic area in the US, often hikes outdoors with the owner and contacts grassland and woodlands. Recently presented with mild lethargy, anorexia and occasional lameness (suspected early symptoms of Lyme disease). Multiple ticks were found on the body upon physical examination, and early Lyme disease (infection with Borrelia burgdorferi transmitted by ticks) was confirmed by veterinary testing.
Usage regimen: First, symptomatic treatment with antibiotics (doxycycline) as directed by a veterinarian; meanwhile, canine formulation 3.57mL (1.0g fluralaner) at a dosage of ≥25mg per kg body weight, applied topically to the skin of the shoulder blade area on the back, administered every 12 weeks. Combined with environmental tick elimination, daily physical tick checks, and Lyme disease vaccination after veterinary consultation to establish a multi-modal prevention and control system.
Efficacy: All ticks on the body fell off within 48 hours after administration, effectively blocking the further transmission of Lyme disease spirochetes; lethargy and anorexia relieved, and lameness disappeared 1 week later; no recurrent tick infestation or Lyme disease during 6 months of continuous use with strict periodic administration. The pet’s mental state and appetite returned to normal, successfully avoiding the progression of Lyme disease to the chronic phase (causing joint swelling and kidney damage). This is consistent with the veterinary experts’ recommendation of year-round tick control for dogs, making this product a reliable tick-blocking option for dogs in Lyme disease-endemic areas.
(1) Applicable Scenarios
(2) Dosage
|
Applicable Pet |
Dosage Standard |
Corresponding Specification and Usage Instructions |
|
Dog |
≥25mg per kg body weight, every 12 weeks |
1. Body weight ≤10kg: 0.89mL specification (0.25g), 1 vial per administration; 2. 10kg < body weight ≤20kg: 1.79mL specification (0.5g), 1 vial per administration; 3. 20kg < body weight ≤40kg: 3.57mL specification (1.0g), 1 vial per administration; 4. 40kg < body weight ≤56kg: 5.0mL specification (1.4g), 1 vial per administration |
|
Cat |
≥40mg per kg body weight, every 12 weeks for routine use; every 8 weeks for Dermacentor variabilis infestation |
Body weight ≥1.2kg (≥11 weeks of age): 0.4mL specification (112.5mg), 1 vial per administration; Contraindicated for pets with body weight <1.2kg or age <11 weeks |
(3) Administration Method (Topical use; avoid contact of the liquid with human and pet eyes at all times)